Co-funding Institute(s):
National Heart, Lung, and Blood Institute (NHLBI)
Workshop on Clinical Trial Endpoints for Acute Graft-versus-Host Disease (Acute GVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT), and the Identification of Future Scientific Directions Needed to the Prevention of Acute GVHD
May 19, 2009 - May 20, 2009
Bethesda, MD, United States
Contact for additional information: Dr. Nancy L. DiFronzo, NHLBI 301-435-0065
DescriptionThe primary focus will be on validated endpoints that are ready for incorporation into clinical trials now or in the near future, and on methods to address confounding issues unique to studies of Acute GVHD. These will be used by the NHLBI-sponsored Blood and Marrow Transplant Clinical Trials Network (BMT CTN), and the materials will be made available publicly so that the endpoints may also be used by the oncology cooperative groups and corporate sponsors. The primary focus will be on validated endpoints that are ready for incorporation into clinical trials now or in the near future, and on methods to address confounding issues unique to studies of Acute GVHD. These will be used by the NHLBI-sponsored Blood and Marrow Transplant Clinical Trials Network (BMT CTN), and the materials will be made available publicly so that the endpoints may also be used by the oncology cooperative groups and corporate sponsors.